Ping An Biomedical (PASW) Current Deferred Revenue (2024 - 2025)
Ping An Biomedical posted quarterly Current Deferred Revenue of $9749.0 for Q3 2025, down 95.82% year-on-year from $233500.2 in Q3 2024, and down 90.66% on a QoQ basis from $104412.0 in Q1 2025.
Ping An Biomedical (PASW) has 2 years of Current Deferred Revenue data on file, last reported at $9749.0 in Q3 2025.
- For the quarter ending Q3 2025, Current Deferred Revenue fell 95.82% year-over-year to $9749.0; the trailing twelve-month figure through Sep 2025 stood at $9749.0 (down 95.82% YoY), and the FY2025 full-year result was $9801.0, down 95.8% from the prior year.
- Current Deferred Revenue for Q3 2025 stood at $9749.0, down from $104412.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $233500.2 in Q3 2024 and bottomed at -$60392.2 in Q1 2024.
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9,748.96 |
| Mar 31, 2025 | 104,412.00 |
| Sep 30, 2024 | 233,500.24 |
| Mar 31, 2024 | -60,392.18 |